The Issue is being made in terms of Rule 19(2)(b) of the Securities Contracts Regulation Rules, 1957, as amended (SCRR). read with Regulation 41 of the SEBI ICDR Regulations. The Issue is being made in accordance with Regulation 26(2) of the SEBI ICDR Regulations, through the Book Building Process wherein at least 75% of the Issue was made available for allocation on a proportionate basis to Qualified Institutional Buyers ("QIBs") (the "QIB Portion"), provided that our Company in consultation with the BRLM. allocated up to 60% of the QIB Portion to Anchor Investors on a discretionary basis ("Anchor Investor Portion"). One-third of the Anchor Investor Portion was reserved for domestic Mutual Funds, subject to valid Bids being received from the domestic Mutual Funds at or above the Anchor Investor Allocation Price. 5% of the QIB Portion (excluding the Anchor Investor Portion) was made available for allocation on a proportionate basis to Mutual Funds only, and the remainder of the QIB Portion was made available for allocation on a proportionate basis to all QIBs (other than Anchor Investors), including Mutual Funds, subject to valid Bids being received at or above the Issue Price. Further, not more than 15% of the Issue was made available for allocation on a proportionate basis to Non-Institutional Bidders and not more than 10% of the Issue was made available for allocation to Retail Individual Bidders in accordance with the SEBI ICDR Regulations, subject to valid Bids being received from them at or above the Issue Price. All Bidders, other than Anchor Investors, were mandatorily required to participate in the Issue through an Application Supported by Blocked Amount ("ASBA") process including through UPI mode (as applicable) by providing details of their respective bank account which will be blocked by the Self Certified Syndicate Banks ("SCSBs"). Anchor Investors were not permitted to participate in the Anchor Investor Portion through the ASBA Process. For details, see "Issue Procedure" on page 391 of the Prospectus.

The Issue received 2,791 applications for 9,613,000 Equity Shares (prior to technical rejections) resulting in 2.7454 times subscription as disclosed in Prospectus. The details of the applications received in the Issue from Retail Individual Bidders. Non-Institutional Bidders, and QIBs are as under (before technical rejections):

Final Demand

A summary of the final demand as per the BSE and the NSE as on the Bid/Issue Closing Date at different Bid prices is as under:

The Basis of Allotment was finalized in consultation with the Designated Stock Exchange, being the BSE on January 30, 2019.

A. Allotment to Retail Individual Investors (After Technical Rejections)

The Basis of Allotment to the Retail Individual Bidders, who have bid at cut-off or at the Issue Price of Rs. 66 per Equity Share (less discount of Rs. 3 per Equity Share to the Issue Price), was finalized in consultation with the BSE. This category has been subscribed to the extent of 2.40587 times. The total number of Equity Shares Allotted in Retail Individual Bidders category is 350,144 Equity Shares to 1,750 successful applicants. The category-wise details of the Basis of Allotment are as under:

1 additional share has been allotted to 144 allottes from amongst 262 successful applicants from the categories 400-3000 (i.e excluding successful applicants from category 200) in the ratio of 72:131.

B. Allotment to Non Institutional Investors (After Technical Rejections)

The Basis of Allotment to the Non-Institutional Bidders, who have bid at the Issue Price of 7.66 per Equity Share or above, was finalized in consultation with the BSE. This category has been subscribed to the extent of 8,17416 times. The total number of Equity Shares allotted in this category is 525,216 Equity Shares to 38 successful applicants. The category-wise details of the Basis of Allotment are as under:

C. Allotment to QIBs (Excluding Anchor Investors) (After Technical Rejections)

Allotment to QIBs. who have bid at the Issue Price of Rs. 66 per Equity Share, has been done on a proportionate basis in consultation with the BSE. This category has been subscribed to the extent of 1.28746 times of Net QIB portion. As per the SEBI Regulations. Mutual Funds were allocated 5% of the Equity Shares of Net QIB portion available i.e. 52,896 Equity Shares and other QIBs and unsatisfied demand of Mutual Funds were allotted the remaining available Equity Shares i.e. 1,005,005 Equity Shares on a proportionate basis. The total number of Equity Shares allotted in the QIB category is 1,057,901 Equity Shares, which were allotted to 5 successful Applicants.

Unsubscribed QIB MF portion of 52,896 Equity shares spilled over to Other QIB Category.

D. Allotment to Anchor Investors

The Company in consultation with the BRLM has Allocated 1,568,181 Equity Shares to 2 Anchor Investors through 2 Applications at the Anchor Investor Issue Price of Rs. 66 per Equity Shares in accordance with the SEBI Regulations. This represents 60 % of the QIB Category.

The Board of Directors of our Company at its meeting held on January 31, 2019 has taken on record the basis of allotment of Equity Shares approved by the Designated Stock Exchange, being BSE and has allotted the Equity Shares to various successful applicants.

The Allotment Advice Cum Refund Intimation will be dispatched to the address of the investors as registered with the depositories. Further, instructions to the SCSBs have been dispatched/mailed for unblocking of funds and transfer to the Public Issue Account on January 30, 2019 and payment to non-Syndicate brokers will be issued on February 01, 2019.

The Refund Advices have been over-printed with the bank account details as registered, if any, with the depositories. The Equity Shares allotted to the successful allottees have been uploaded on January 31, 2019 for credit into the respective beneficiary accounts subject to validation of the account details with the depositories concerned.

In case the unblocking of funds or credit of shares is not received within six working days, investors may contact the Registrar to the issue at the address given below

The Company is in the process of filing the Listing application with BSE and NSE on or before February 01, 2019. Our Company is taking steps to get the Equity Shares admitted for trading on the BSE and NSE within six working days of the closure of the Issue.

Note: All capitalized terms used and not defined herein shall have the respective meanings assigned to them in the Prospectus.

INVESTORS PLEASE NOTE

These details of the Allotment made shall be hosted on the website of Registrar to the Issue; Karvy Fintech Private Limited at www.karisma.karvy.com

All future correspondence in this regard may kindly be addressed to the Registrar to the Issue quoting full name of the First/ Sole applicant, Serial number of the ASBA form, Bidders DP ID, Client ID, PAN, date of submission of Bid cum Application form, address of the Bidder, Acknowledgement slip received from the Designated Intermediary, number of Equity Shares bid for, name of the Member of the Syndicate, place where the bid was submitted and payment details at the address given below:

Karvy Fintech Private Limited
Karvy Selenium Tower B, Plot 31-32, Gachibowli Financial District, Nanakramguda, Hyderabad - 500 032 Telangana, India.
Tel: +91 40 6716 2222; Fax: +91 40 2343 1551; Email: einward.ris@karvy.com;
Investor grievance email: xelpmoc.ipo@karvy.com
Website: www.karvyfmtech.com; Contact Person: M Murali Krishna; SEBI Registration No.: INR000000221
	For XELPMOC DESIGN AND TECH LIMITED
	On behalf of the Board of Directors
Place : Bengaluru	Sd/-
Date   : January 31, 2019	Company Secretary & Compliance Officer

THE LEVEL OF SUBSCRIPTION SHOULD NOT BE TAKEN TO BE INDICATIVE OF EITHER THE MARKET PRICE OF THE EQUITY SHARES ON LISTING OR THE BUSINESS PROSPECTS OF XELPMOC DESIGN AND TECH LIMITED.

XELPMOC DESIGN AND TECH LIMITED has filed a Prospectus with the Registrar of Companies, Bengaluru, Karnataka. The Prospectus will be available on the website of the SEBI at www.sebi.gov.in, on the websites of the BSE and NSE at www.bseindia.com and www.nseindia.com as well as on the website of the BRLM at www.ibcapital.in, respectively. Investors should note that investment in equity shares involves a high degree of risk and for details relating to the same, see the section titled 'Risk Factors' of the Prospectus. The Equity Shares have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the 'Securities Act'), or any state securities laws in the United States and may not be offered or sold within the United States or to, or for the account or benefit of, U.S Persons (as defined in Regulation S under the Securities Act) except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable state securities laws in the United States Accordingly, the Equity Shares are only being offered and sold (i) to persons in the United States or to, or for the account or benefit of. U.S. Persons, in each case that are both 'qualified institutional buyers' (as defined in Rule 144A under the Securities Act), and 'qualified purchasers' (as defined under the U.S. Investment Company Act of 1940, as amended (the ‘Investment Company Act') in transactions exempt from or not subject to the registration requirements of the Securities Act, and in reliance upon section 3(c)(7) of the Investment Company Act; or (ii) outside the United States to investors that are not U.S. Persons nor persons acquiring for the account or benefit of U.S. Persons in offshore transactions in reliance on Regulation Sunder the Securities Act and the applicable laws of the jurisdiction where those offers and sales occur.